A recognised Biotechnology business leader, Jeremy has spent over 10 years in the industry. Starting in Business Development at Genentech, Inc, Jeremy executed over 35 licensing and collaboration transactions. He then led Business Development at Opsona Therapeutics prior to co-founding TriMod in 2011.

Jeremy’s business acumen is underpinned by strong scientific training at the University of California, San Francisco and NUI Galway (Ireland).

Prof Mills is a globally recognized and distinguished leader in the field of Immunology and brings over 30 years of academic (TCD, University College London, NUI Maynooth) and entrepreneurial (Co-Founder of Opsona Therapeutics) excellence to TriMod. Prof Mills has published ›170 peer-reviewed articles, is co-inventor on 14 patents and applications, is Director of the Immunology Research Centre at TCD and is a member of the Royal Irish Academy.

Dr Seizinger is currently Executive Chairman of Opsona Therapeutics and brings extensive Oncology and Industry Experience (GPC Biotech (CEO), Genome Therapeutics (CSO) and Bristol-Myers Squibb (VP Oncology Drug Discovery)) as well as Academic expertise (Harvard, Princeton, Max Planck) to TriMod. He is the recipient of a number of scientific awards and has authored over one hundred publications.

Professor Armstrong is a Consultant Radiation Oncologist and is a Board Member and ex-chairman of the Irish Cancer Society. Prof Armstrong trained and was Chief Resident at MSKCC. Prof Armstrong is currently Director of Research at St. Lukes Hospital, Dublin. He was a founding member and past chairman of the Irish Clinical Oncology Research Group and is the PI for several clinical trials. He is Medical Director for UPMC Cancer Centres Ireland.